Interpreting registry-derived drug studies: does societal context matter?

Arthritis Rheum. 2009 Nov;60(11):3155-7. doi: 10.1002/art.24880.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Antirheumatic Agents / adverse effects
  • Antirheumatic Agents / economics*
  • Antirheumatic Agents / therapeutic use*
  • Arthritis, Rheumatoid / drug therapy*
  • Arthritis, Rheumatoid / economics*
  • Hematologic Neoplasms / epidemiology
  • Humans
  • Methotrexate / adverse effects
  • Methotrexate / economics
  • Methotrexate / therapeutic use
  • Registries*
  • Risk Factors
  • Severity of Illness Index
  • Single-Payer System / economics
  • Skin Neoplasms / epidemiology
  • Socioeconomic Factors
  • Sweden / epidemiology
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors
  • United States

Substances

  • Antirheumatic Agents
  • Tumor Necrosis Factor-alpha
  • Methotrexate